2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL2586310

Nc1nc(N)c2[nH]cnc2n1.OC[C@@H]1CCC(O)O1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.56
GDA Q9Y2T3 1/20 0.56
CDK2 P24941 12/20 0.43
CDK1 P06493 11/20 0.43
CCNB1 P14635 11/20 0.43
CCNA2 P20248 11/20 0.43
CCNA1 P78396 11/20 0.43
MAP3K5 Q99683 2/20 0.42
PIN1 Q13526 2/20 0.42
CCNB2 O95067 1/20 0.42
MAPK3 P27361 1/20 0.42
CLK1 P49759 1/20 0.42
CDK5 Q00535 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
DPP4 P27487 1/20 0.40
MGMT P16455 7/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,6-Diaminopurine SCHEMBL7801065 0.80 PDPK1 (0.55) PDPK1GDACDK2CDK1CCNB1
SCHEMBL8720826 0.79 PDPK1 (0.43) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL10774603 0.78 PDPK1 (0.59) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL2934952 0.78 PDPK1 (0.59) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL6241914 0.78 PDPK1 (0.59) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL28206545 0.77 PDPK1 (0.96) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL10520728 0.76 MAPK1 (0.57) PDPK1GDADPP4ADORA2AADORA1
2,6-Diaminopurine SCHEMBL28083713 0.75 PDPK1 (0.79) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL24053 0.75 PDPK1 (1.00) PDPK1GDACDK2CDK1CCNB1
2,6-Diaminopurine SCHEMBL443468 0.75 PDPK1 (0.55) PDPK1GDACDK2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563367-A1 METHODS OF TREATING RETROVIRAL INFECTIONS AND RELATED DOSAGE REGIMES Chimerix, Inc. (US) 2013-03-06 EP disclosed
WO-2011139709-A2 METHODS OF TREATING RETROVIRAL INFECTIONS AND RELATED DOSAGE REGIMES CHIMERIX, INC. (US) 2011-11-10 WO disclosed